Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked. The layout shows the standard ClinicalTrials.gov header and footer, but the main content area presents the error instead of the study details.SummaryDifference19%

- Check46 days agoChange DetectedThe page revision has been updated from v3.6.5 to v3.6.6, signaling a new version of the page. This update is a metadata change and does not alter the study details or eligibility information presented.SummaryDifference0.1%

- Check53 days agoChange DetectedAn NIH funding reference for 2015 was added under Other Study ID Numbers. This records a U.S. NIH grant/contract associated with the study.SummaryDifference0.1%

- Check67 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page metadata. No substantive content of the study details appears to be altered by this change.SummaryDifference0.0%

- Check82 days agoChange DetectedPlatform revision updated from v3.6.3 to v3.6.4, representing a maintenance update to the underlying system without altering the study information displayed.SummaryDifference0.0%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.